Zobrazeno 1 - 10
of 6 593
pro vyhledávání: '"Anita, K."'
Autor:
Matthew E. Stokes, Kerstin Wenzl, C. Chris Huang, María Ortiz, Chih-Chao Hsu, Matthew J. Maurer, Nicholas Stong, Yumi Nakayama, Lei Wu, Hsiling Chiu, Ann Polonskaia, Samuel A. Danziger, Fadi Towfic, Joel Parker, Rebecca L. King, Brian K. Link, Susan L. Slager, Vivekananda Sarangi, Yan W. Asmann, Joseph P. Novak, Akshay Sudhindra, Stephen M. Ansell, Thomas M. Habermann, Patrick R. Hagner, Grzegorz S. Nowakowski, James R. Cerhan, Anne J. Novak, Anita K. Gandhi
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-19 (2024)
Abstract Immunochemotherapy has been the mainstay of treatment for newly diagnosed diffuse large B-cell lymphoma (ndDLBCL) yet is inadequate for many patients. In this work, we perform unsupervised clustering on transcriptomic features from a large c
Externí odkaz:
https://doaj.org/article/4dae5fe5634e4259b6d610f0ad207e8d
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/92e17ed7028040689bf1032734a7c592
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 17, Iss 1 (2024)
Background Withdrawals of drug indications may reveal potential inadequacies in the regulatory approval processes of new drugs. Understanding potential weaknesses of the regulatory approval process is paramount given the increasing use of expedited p
Externí odkaz:
https://doaj.org/article/67e6023f0d1c4d449c59706d21db22e0
Autor:
Kerstin Wenzl, Matthew E. Stokes, Joseph P. Novak, Allison M. Bock, Sana Khan, Melissa A. Hopper, Jordan E. Krull, Abigail R. Dropik, Janek S. Walker, Vivekananda Sarangi, Raphael Mwangi, Maria Ortiz, Nicholas Stong, C. Chris Huang, Matthew J. Maurer, Lisa Rimsza, Brian K. Link, Susan L. Slager, Yan Asmann, Patrizia Mondello, Ryan Morin, Stephen M. Ansell, Thomas M. Habermann, Thomas E. Witzig, Andrew L. Feldman, Rebecca L. King, Grzegorz Nowakowski, James R. Cerhan, Anita K. Gandhi, Anne J. Novak
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Recent genetic and molecular classification of DLBCL has advanced our knowledge of disease biology, yet were not designed to predict early events and guide anticipatory selection of novel therapies. To address this unmet need, we used an int
Externí odkaz:
https://doaj.org/article/01ad00fd8b6b4753b3568b00e0172eef
Autor:
Valerie Le Sage, Nicole C. Rockey, Andrea J. French, Ryan McBride, Kevin R. McCarthy, Lora H. Rigatti, Meredith J. Shephard, Jennifer E. Jones, Sydney G. Walter, Joshua D. Doyle, Lingqing Xu, Dominique J. Barbeau, Shengyang Wang, Sheila A. Frizzell, Michael M. Myerburg, James C. Paulson, Anita K. McElroy, Tavis K. Anderson, Amy L. Vincent Baker, Seema S. Lakdawala
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract Influenza A viruses in swine have considerable genetic diversity and continue to pose a pandemic threat to humans due to a potential lack of population level immunity. Here we describe a pipeline to characterize and triage influenza viruses
Externí odkaz:
https://doaj.org/article/53d1d7ae1d604556b2b4b78a61ba2a10
Autor:
Leena Arora, Debarun Patra, Soumyajit Roy, Sidhanta Nanda, Navneet Singh, Anita K. Verma, Anuradha Chakraborti, Suman Dasgupta, Durba Pal
Publikováno v:
Molecular Oncology, Vol 18, Iss 5, Pp 1278-1300 (2024)
In most cancers, tumor hypoxia downregulates the expression of C‐C motif chemokine 2 (CCL2), and this downregulation has been implicated in monocyte infiltration and tumor progression; however, the molecular mechanism is not yet clear. We compared
Externí odkaz:
https://doaj.org/article/e58c5ebc3fec48f9932ddecd102c1a0c
Autor:
Laurent, Camille, Trisal, Preeti, Tesson, Bruno, Seth, Sahil, Beyou, Alicia, Roulland, Sandrine, Lesne, Bastien, Van Acker, Nathalie, Cerapio, Juan-Pablo, Chartier, Loïc, Guille, Arnaud, Stokes, Matthew E., Huang, C. Chris, Huet, Sarah, Gandhi, Anita K., Morschhauser, Franck, Xerri, Luc
Publikováno v:
In Blood 12 December 2024 144(24):2503-2516
Publikováno v:
Cancer Medicine, Vol 12, Iss 23, Pp 21545-21560 (2023)
Abstract Background Genome‐wide measures of genetic disruption such as tumour mutation burden (TMB) and mutation signatures are emerging as useful biomarkers to stratify patients for treatment. Clinicians commonly use cancer gene panels for tumour
Externí odkaz:
https://doaj.org/article/9011a13d518c438488d4c9e578e0d294